Mary's Medicinals Slams RX Green's Recklessness and Ineptitude

Note: We have covered the ongoing litigation between Colorado’s Mary’s Medicinals and RX Green, including when Mary’s Medicinals filed its suit in March and the counter suit filed by RX Green last week. Below is a press release issued by Mary’s Medicinals in response:

Mary's Medicinals Logo

Mary’s Medicinals Responds to RXGreen Counter Suit

Attorneys Perplexed By Erroneous Information & Unknown Parties Named in Suit

DENVER, June 6, 2016Mary’s Medicinals, developer of award-winning cannabis products including the first Transdermal Cannabis Patch, today responded to RXGreen’s counter lawsuit.

On March 30, 2016, Mary’s Medicinals announced that due to an ongoing documented pattern of harassment, fraudulent reporting and the dissemination of false information, it had filed a lawsuit in United States District Court for the District of Colorado against Joshua Meacham, founding partner of RXGreen Cannabis, for charges including libel, slander, civil conspiracy, intentional interference with prospective business relations, and intentional interference with contractual relations.

On June 2, 2016, RXGreen issued a press release announcing a counter suit, alleging that Eleutherian Enterprises had engaged in libel, slander, civil conspiracy, defamation and intentional interference with contractual relations. Mary’s Medicinals is not in any way affiliated with (or aware of) a company called Eleutherian Enterprises. Additional parties named in the lawsuit, including David Karas – are also unknown to Mary’s Medicinals, and are presumed to be included out of recklessness and ineptitude.

The desperation in this countersuit is obvious. Based on its founder’s history of legal issues and fraud allegations, we are not surprised that RXGreen countered the suit, but the facts are clear. Mary’s case is based on well documented evidence gathered and reviewed by leading private investigators as well as state agents – and we are confident that the facts will come to light and this case will run its course.

robert-t-hobanRobert Hoban, Counsel to Mary’s Medicinals

As we are in midst of litigation, we will not issue further comments until the suit is concluded. We intend to let the merits of our claims, and the utter lack of merit of their allegations, speak for themselves.

Original press release:

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter